(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CONVERSALL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CONVERSALL

ST13

US500000090902865

Class

5

Filing

90902865

Registration

6908553

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

03/07/2024

Trademark type

Word

Nice classes

5

Filing date

08/25/2021

Registration date

11/22/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/22/2022

Last transaction

03/07/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/26/2021

First use in commerce

08/23/2022

Drawing code

4

Owner type

03

Owner location

Newport Beach, CA, US

Examiner

HA, PAULINE T.

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vivera Pharmaceuticals Inc.

Representatives

Vivera Pharmaceuticals Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Medicinal preparations for mental health disorders; Medicinal preparations for stuttering; Medicinal preparations for diabetes; Dietary supplements; Drug delivery agents in the form of sublingual tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of sublingual gel strips that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of mental health disorders; Medical preparations for the treatment of stuttering; Medical preparations for the treatment of diabetes; Nutritional supplements; Pharmaceutical preparations for mental health disorders; Pharmaceutical preparations for stuttering; Pharmaceutical preparations for diabetes; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Sexual stimulant preparations in the form of sublingual tablets containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual capsules containing sildenafil citrate; Sexual stimulant preparations in the form of sublingual gel strips containing sildenafil citrate

Publications

History of USPTO decisions and trademark events.

18 publications found

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

03/07/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

03/07/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/22/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/22/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/18/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/17/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/06/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/05/2022

IUAF

USE AMENDMENT FILED

09/22/2022

EISU

TEAS STATEMENT OF USE RECEIVED

09/22/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/22/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/25/2022

PUBO

PUBLISHED FOR OPPOSITION

01/25/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/22/2021

DOCK

ASSIGNED TO EXAMINER

12/21/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/12/2021

NWAP

NEW APPLICATION ENTERED

08/28/2021

Continuous trademark protection

Get notified about every new filing that threatens CONVERSALL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.